OBJECTIVE: Cytokine-induced killer cells (CIK) is a type of immune cell with antitumor activity induced by a variety of cytokines. Regulatory T cells (Treg) is a T cell subgroup featured as immunosuppressive function. Existing CIK cultivation system may inevitably induce Treg. Forkhead box protein 3 (Foxp3) is an essential transcription factor for Treg function. This study aimed to investigate the effects of CIK on the leukemia cell HL-60. MATERIALS AND METHODS: This work silenced Foxp3 expression on the basis of CIK induction, aiming to investigate its killing effect on HL-60 cells. Peripheral blood mononuclear cells were separated and differentiated to CIK in vitro. CD3(+)CD56(+) and CD4(+)CD25(+)Foxp3(+) Treg cells were detected by flow cytometry. CIK cells were co-cultured with HL-60 cells under the effector-target ratio at 20:1, 10:1, and 5:1, respectively. The killing activity of CIK on HL-60 cells was determined by CCK-8 assay. RESULTS: The ratio of CD3(+), CD3(+)CD8(+), and CD3(+)CD56(+) cells gradually increased during CIK induction. Foxp3 interference significantly reduced Treg cell ratio on the 7th day (p < 0.05). Treg cell ratio was significantly lower in Foxp3 interference group at 1.62% +/- 0.07% compared with control (p < 0.05). The killing activity of CIK on HL-60 cells enhanced following the increase of effector-target ratio. Interference of Foxp3 significantly elevated the killing activity of CIK on HL-60 cells with effector-target ratio dependence (p < 0.05). CIK can effectively suppress HL-60 cell growth. Treg significantly inhibited the anti-tumor effect of CIK. CONCLUSIONS: Interference of Foxp3 expression significantly declined Treg level and attenuated its suppression impact on CIK, thus enhancing the killing effect of CIK on HL-60 cells.
机构:
Tabriz Univ Med Sci, Shahid Ghazi Hosp, Dept Med Immunol, Immunol Res Ctr, Tabriz, Iran
Tabriz Univ Med Sci, Shahid Ghazi Hosp, Fac Med, Dept Clin Biochem, Tabriz, IranTabriz Univ Med Sci, Shahid Ghazi Hosp, Dept Med Immunol, Immunol Res Ctr, Tabriz, Iran
Karami, Hadi
Baradaran, Behzad
论文数: 0引用数: 0
h-index: 0
机构:
Tabriz Univ Med Sci, Shahid Ghazi Hosp, Dept Med Immunol, Immunol Res Ctr, Tabriz, IranTabriz Univ Med Sci, Shahid Ghazi Hosp, Dept Med Immunol, Immunol Res Ctr, Tabriz, Iran
Baradaran, Behzad
Esfehani, Ali
论文数: 0引用数: 0
h-index: 0
机构:
Tabriz Univ Med Sci, Shahid Ghazi Hosp, Hematol & Oncol Res Ctr, Tabriz, IranTabriz Univ Med Sci, Shahid Ghazi Hosp, Dept Med Immunol, Immunol Res Ctr, Tabriz, Iran
Esfehani, Ali
Sakhinia, Masoud
论文数: 0引用数: 0
h-index: 0
机构:
Univ Liverpool, Fac Med, Liverpool L69 3BX, Merseyside, EnglandTabriz Univ Med Sci, Shahid Ghazi Hosp, Dept Med Immunol, Immunol Res Ctr, Tabriz, Iran
Sakhinia, Masoud
Sakhinia, Ebrahim
论文数: 0引用数: 0
h-index: 0
机构:
Tabriz Univ Med Sci, Tabriz Genet Anal Ctr, TB & Lung Dis Res Ctr, Dept Med Genet,Fac Med, Tabriz, IranTabriz Univ Med Sci, Shahid Ghazi Hosp, Dept Med Immunol, Immunol Res Ctr, Tabriz, Iran
机构:
Chinese Acad Sci, Shanghai Inst Mat Med, Div Antitumor Pharmacol, State Key Lab Drug Res,Shanghai Inst Biol Sci, Shanghai 200031, Peoples R ChinaChinese Acad Sci, Shanghai Inst Mat Med, Div Antitumor Pharmacol, State Key Lab Drug Res,Shanghai Inst Biol Sci, Shanghai 200031, Peoples R China
Liu, WJ
Jiang, JF
论文数: 0引用数: 0
h-index: 0
机构:
Chinese Acad Sci, Shanghai Inst Mat Med, Div Antitumor Pharmacol, State Key Lab Drug Res,Shanghai Inst Biol Sci, Shanghai 200031, Peoples R ChinaChinese Acad Sci, Shanghai Inst Mat Med, Div Antitumor Pharmacol, State Key Lab Drug Res,Shanghai Inst Biol Sci, Shanghai 200031, Peoples R China
Jiang, JF
Xiao, D
论文数: 0引用数: 0
h-index: 0
机构:
Chinese Acad Sci, Shanghai Inst Mat Med, Div Antitumor Pharmacol, State Key Lab Drug Res,Shanghai Inst Biol Sci, Shanghai 200031, Peoples R ChinaChinese Acad Sci, Shanghai Inst Mat Med, Div Antitumor Pharmacol, State Key Lab Drug Res,Shanghai Inst Biol Sci, Shanghai 200031, Peoples R China
Xiao, D
Ding, J
论文数: 0引用数: 0
h-index: 0
机构:
Chinese Acad Sci, Shanghai Inst Mat Med, Div Antitumor Pharmacol, State Key Lab Drug Res,Shanghai Inst Biol Sci, Shanghai 200031, Peoples R ChinaChinese Acad Sci, Shanghai Inst Mat Med, Div Antitumor Pharmacol, State Key Lab Drug Res,Shanghai Inst Biol Sci, Shanghai 200031, Peoples R China